Published in J Urol on April 01, 1987
A novel approach to bilateral hand-assisted laparoscopic nephrectomy for autosomal dominant polycystic kidney disease. Surg Endosc (2006) 0.90
Evaluation and management of pain in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis (2010) 0.86
Ablation of symptomatic cysts using absolute ethanol in 11 patients with autosomal-dominant polycystic kidney disease. Korean J Radiol (2004) 0.83
A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease. Nephrol Dial Transplant (2014) 0.82
Transcatheter arterial embolization using ethanol in a dialysis patient for contracting enlarged polycystic kidneys. Korean J Radiol (2010) 0.77
Cyst ablation using a mixture of N-butyl cyanoacrylate and iodized oil in patients with autosomal dominant polycystic kidney disease: the long-term results. Korean J Radiol (2009) 0.76
Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization. J Am Soc Nephrol (2015) 0.75
Functional and therapeutic importance of purinergic signaling in polycystic kidney disease. Am J Physiol Renal Physiol (2016) 0.75
Which cyclosporin formulation? Lancet (1996) 3.34
Consensus statement on the live organ donor. JAMA (2000) 3.29
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int (2001) 2.81
Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int (1997) 2.47
Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis (1996) 2.30
Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation (1996) 2.24
Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis (1998) 2.16
The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis (1979) 1.83
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis (2000) 1.68
Cyst decompression surgery for autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1992) 1.68
Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther (1975) 1.59
Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis (1989) 1.57
Cyclopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: a promising target for chemotherapy. Eur J Cancer (2000) 1.48
Renal manifestations of sarcoidosis. Arch Intern Med (1981) 1.47
Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int (1997) 1.43
Acute renal failure from ticrynafen. N Engl J Med (1979) 1.40
Vancomycin revisited. Perit Dial Int (1997) 1.39
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess. J Infect Dis (1988) 1.36
Action and toxicity of cyclosporine. Annu Rev Med (1986) 1.35
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care (2001) 1.32
Biochemical changes during development of mouse mammary tissue in organ culture. J Endocrinol (1970) 1.31
Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int (2001) 1.30
Effect of cations on the consideration of hen erythrocyte nuclei and its relation to gene activation. Exp Cell Res (1972) 1.29
Peritoneal dialysis-related peritonitis treatment recommendations. 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis. Perit Dial Int (1993) 1.26
Stimulation by insulin of the formation of ribonucleic acid and protein by mammary tissues in vitro. Biochem J (1966) 1.26
Lead nephropathy. Kidney Int (1985) 1.24
Increase in activity of glucose 6-phosphate dehydrogenase in mouse mammary tissue cultured in insulin. Biochem J (1969) 1.24
Application of simple chromatographic methods for the diagnosis of defects in pyrimidine degradation. Clin Chem (1993) 1.22
Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int (1996) 1.22
The nephropathy of the nail-patella syndrome. Clinicopathologic analysis of 11 kindred. Am J Med (1973) 1.20
Role of histones in chromatin condensation. Eur J Biochem (1974) 1.17
Increase during lactation of RNA synthesis b isolated liver nuclei. Biochim Biophys Acta (1968) 1.15
Needle tract seeding after percutaneous renal adenocarcinoma aspiration. J Urol (1986) 1.15
Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative. Am J Kidney Dis (2001) 1.14
Drug prescribing in renal failure: dosing guidelines for adults. Am J Kidney Dis (1983) 1.13
Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects. Clin Pharmacol Ther (1988) 1.12
Endogenous creatinine clearance as a clinical measure of glomerular filtration rate. Br Med J (1971) 1.12
Swelling of hen erythrocyte nuclei in cytoplasm from Xenopus eggs. Exp Cell Res (1972) 1.12
Drug-related syndromes in clinical nephrology. Ann Intern Med (1977) 1.10
Guidelines for drug therapy in renal failure. Ann Intern Med (1977) 1.10
Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat. Am J Pathol (1978) 1.10
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol (1995) 1.09
Nephrotoxic acute renal failure due to common drugs. Am J Physiol (1981) 1.09
Renal function 27 years after unilateral nephrectomy for related donor kidney transplantation. J Urol (1988) 1.08
Attenuation of experimental tobramycin nephrotoxicity by ticarcillin. Antimicrob Agents Chemother (1985) 1.08
Cyclosporine nephrotoxicity. Ann Intern Med (1983) 1.07
Clinical experience with hinged silicone penile implants for impotence. J Urol (1980) 1.06
Renal cholesterol accumulation: a durable response after acute and subacute renal insults. Am J Pathol (2001) 1.05
Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis (1985) 1.04
Effect of sodium intake on gentamicin nephrotoxicity in the rat. Proc Soc Exp Biol Med (1976) 1.04
Reversibility of gentamicin nephrotoxicity in rats: recovery during continuous drug administration. Proc Soc Exp Biol Med (1979) 1.04
Role of splenectomy in renal transplantation. Urology (1973) 1.04
Drug dosing guidelines in patients with renal failure. West J Med (1992) 1.03
Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys. Kidney Int (1987) 1.03
Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agents Chemother (1988) 1.03
Culture-negative CAPD peritonitis: the Network 9 Study. Adv Perit Dial (1994) 1.03
Djenkol bean poisoning (djenkolism): an unusual cause of acute renal failure. Am J Kidney Dis (1995) 1.02
Drug therapy in renal failure: dosing guidelines for adults. Part II: sedatives, hypnotics, and tranquilizers; cardiovascular, antihypertensive, and diuretic agents; miscellaneous agents. Ann Intern Med (1980) 1.02
Cefazolin as empiric therapy in hemodialysis-related infections: efficacy and blood concentrations. Am J Kidney Dis (1998) 1.02
Complications of percutaneous needle biopsy of the kidney. Am J Nephrol (1982) 1.01
A guide to drug therapy in renal failure. JAMA (1974) 1.01
Quality of life during and between hemodialysis treatments: role of L-carnitine supplementation. Am J Kidney Dis (1998) 1.01
Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest (1994) 1.01
Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation (1987) 1.01
Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity. Antimicrob Agents Chemother (1991) 1.00
Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction. Kidney Int (1983) 1.00
Ethylene glycol intoxication. Prevention of renal failure by aggressive management. JAMA (1973) 1.00
Induction of contraction in isolated rat aorta by cyclosporine. Transplantation (1987) 1.00
Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int (1983) 0.99
Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens (1998) 0.99
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int (1995) 0.98
Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity. J Infect Dis (1982) 0.97
Cyclosporine-associated hypertension. Am J Med (1988) 0.97
Clinical characteristics and diagnostic considerations in acquired renal cystic disease. Kidney Int (1986) 0.97
Nontuberculous mycobacterial peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis (1983) 0.97
Stimulation by insulin of ornithine decarboxylase activity in cultured mammary tissue. Biochim Biophys Acta (1973) 0.97
Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis. Kidney Int (1999) 0.97
Hernias after transpubic urethroplasty. J Urol (1986) 0.97
Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis (1994) 0.97
SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int (1996) 0.97
Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int (1996) 0.97
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int (1998) 0.96
Analgesic nephropathy--a preventable renal disease. N Engl J Med (1989) 0.96
A practical guide to drug usage in adult patients with impaired renal function. JAMA (1970) 0.96
Impaired biological activity of erythropoietin by cyanate carbamylation. Blood Purif (2000) 0.96
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int (1996) 0.96